|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US8623935||3M HEALTH CARE||Antimicrobial compositions|| |
(5 years from now)
Soluprep is owned by 3M Health Care.
Soluprep contains Chlorhexidine Gluconate; Isopropyl Alcohol.
Soluprep has a total of 1 drug patent out of which 0 drug patents have expired.
Soluprep was authorised for market use on 08 August, 2018.
Soluprep is available in solution;topical dosage forms.
Soluprep can be used as for the preparation of skin prior to surgery; helps reduce bacteria that can potentially cause skin infection.
The generics of Soluprep are possible to be released after 26 July, 2029.
|Drug Exclusivity||Drug Exclusivity Expiration|
|M (M)||Jan 20, 2026|
Market Authorisation Date: 08 August, 2018
Treatment: For the preparation of skin prior to surgery; Helps reduce bacteria that can potentially cause skin infection
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic